Add Yahoo as a preferred source to see more of our stories on Google. NCGA proposes bill known as the Seat Belt Act, which would allow courts to require intelligent speed assistance devices for ...
For those scared of needles but who need GLP-1 receptor agonists to help manage their weight, there might be some good news. Researchers are testing a new oral, small-molecule GLP-1 receptor agonist ...
In SYNCHRONIZE-1, survodutide achieved −12.2% to −13.0% weight loss at 76 weeks versus −5.4% with placebo, with ≥20% loss in 28.5% at 6.0 mg. MRI substudy data showed organ-selective effects: liver ...
The 76-week Phase III SYNCHRONIZE-1 trial investigated survodutide in adults living with obesity or overweight, without type 2 diabetes. Positive topline data announced in April showed that the trial ...
Why is Christian Science in our name? Our name is about honesty. The Monitor is owned by The First Church of Christ, Scientist, and we’ve always been transparent about that. The church publishes the ...
The homesteaders at Mason Dixon Acres install natural stone veneer during the exterior construction phase of their home build. Senate Republicans reject war powers resolution after Trump berates them ...
Anthropic says AI could soon improve without human intervention Development pause will allow society to deal with AI's implications, startup says Previous attempts to halt AI progress have not been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results